Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Adlarity®(donepezil) – New drug approval
March 14, 2022 - Corium announced the FDA approval of Adlarity (donepezil), for the treatment of mild, moderate, and severe dementia of the Alzheimer’s type.
